@article{bb7ef1708b924a0d863fa61a31665170,
title = "Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding",
abstract = "The need for anticoagulation after surgical aortic valve replacement (AVR) with biological prostheses is not well examined.",
keywords = "Aged, Aged, 80 and over, Anticoagulants, Aortic Valve, Cardiovascular Diseases, Denmark, Drug Administration Schedule, Female, Follow-Up Studies, Heart Defects, Congenital, Heart Valve Diseases, Heart Valve Prosthesis Implantation, Hemorrhage, Humans, Incidence, Male, Middle Aged, Registries, Risk, Stroke, Thromboembolism, Warfarin",
author = "Charlotte M{\'e}rie and Lars K{\o}ber and {Skov Olsen}, Peter and Charlotte Andersson and Gunnar Gislason and {Skov Jensen}, Jan and Christian Torp-Pedersen",
year = "2012",
doi = "10.1001/jama.2012.54506",
language = "English",
volume = "308",
pages = "2118--25",
journal = "J A M A: The Journal of the American Medical Association",
issn = "0098-7484",
publisher = "American Medical Association",
number = "20",
}